Matthew Plooster

Currently holds a position at Zevra Therapeutics Inc

3.6

3.6

Position	Company	Period
Independent Director	Zevra Therapeutics Inc	March 1, 2011 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-03-13	2023-03-09	Zevra Therapeutics Inc (ZVRA)	B Purchase	65,553 -30.9% 473.82 US$236,727	65,553 -30.9%	473.82	US$236,727
2022-05-18	2022-05-18	Zevra Therapeutics Inc (ZVRA)	B Purchase	71,360 +45.0% 171.98 US$841,495	71,360 +45.0%	171.98	US$841,495
2022-05-18	2022-05-18	Zevra Therapeutics Inc (ZVRA)	B Purchase	58,018 -29.7% 234.77 US$289,636	58,018 -29.7%	234.77	US$289,636
2022-05-18	2022-05-18	Zevra Therapeutics Inc (ZVRA)	B Purchase	915 +28.6% 4.95 US$4,529	915 +28.6%	4.95	US$4,529
2022-05-18	2022-05-18	Zevra Therapeutics Inc (ZVRA)	B Purchase	695 +27.8% 4.94 US$3,433	695 +27.8%	4.94	US$3,433